{
    "Trade/Device Name(s)": [
        "AfinionTM HbA1c",
        "AfinionTM HbA1c Control",
        "AfinionTM AS100 Analyzer"
    ],
    "Submitter Information": "Axis-Shield PoC AS",
    "510(k) Number": "K050574",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951361"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JJX",
        "JQT"
    ],
    "Summary Letter Date": "July 22, 2005",
    "Summary Letter Received Date": "July 5, 2005",
    "Submission Date": "June 28, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Capillary Blood",
        "Venous Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Na-citrate tube",
        "NaF tube"
    ],
    "Instrument(s)/Platform(s)": [
        "AfinionTM AS100 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Automated in-vitro assay",
        "Reflection measurement",
        "Transmission measurement"
    ],
    "Methodologies": [
        "Quantitative measurement of HbA1c"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for AfinionTM HbA1c assay and controls measured on the AfinionTM AS100 Analyzer for quantitative determination of glycated hemoglobin in whole blood.",
    "Indications for Use Summary": "For in-vitro quantitative determination of glycated hemoglobin (HbA1c) in human blood to monitor long-term metabolic control in diabetes mellitus, used with the AfinionTM AS100 Analyzer system at point-of-care.",
    "fda_folder": "Hematology"
}